| CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma K Rejeski, A Perez, P Sesques, E Hoster, C Berger, L Jentzsch, ... Blood, The Journal of the American Society of Hematology 138 (24), 2499-2513, 2021 | 338 | 2021 |
| Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells P Karschnia, JT Jordan, DA Forst, IC Arrillaga-Romany, TT Batchelor, ... Blood, The Journal of the American Society of Hematology 133 (20), 2212-2221, 2019 | 303 | 2019 |
| The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non‐coding RNA and synonymous mutations S Diederichs, L Bartsch, JC Berkmann, K Fröse, J Heitmann, C Hoppe, ... EMBO molecular medicine 8 (5), 442-457, 2016 | 295 | 2016 |
| Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group P Karschnia, JS Young, A Dono, L Häni, T Sciortino, F Bruno, ST Juenger, ... Neuro-oncology 25 (5), 940-954, 2023 | 225 | 2023 |
| Evidence-based recommendations on categories for extent of resection in diffuse glioma P Karschnia, MA Vogelbaum, M van den Bent, DP Cahill, L Bello, Y Narita, ... European Journal of Cancer 149, 23-33, 2021 | 189 | 2021 |
| Pharmacologic management of cognitive impairment induced by cancer therapy P Karschnia, MW Parsons, J Dietrich The Lancet Oncology 20 (2), e92-e102, 2019 | 109 | 2019 |
| Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic TM Berghaus, P Karschnia, S Haberl, M Schwaiblmair Respiratory medicine 191, 106120, 2022 | 52 | 2022 |
| Severe Candida glabrata pancolitis and fatal Aspergillus fumigatus pulmonary infection in the setting of bone marrow aplasia after CD19-directed CAR T-cell … K Rejeski, WG Kunz, M Rudelius, V Bücklein, V Blumenberg, C Schmidt, ... BMC infectious diseases 21, 1-8, 2021 | 52 | 2021 |
| Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells P Karschnia, KC Miller, AJ Yee, K Rejeski, PC Johnson, N Raje, ... Blood 142 (14), 1243-1248, 2023 | 47 | 2023 |
| Human genetics and molecular mechanisms of vein of Galen malformation D Duran, P Karschnia, JR Gaillard, JK Karimy, MW Youngblood, ... Journal of Neurosurgery: Pediatrics 21 (4), 367-374, 2018 | 46 | 2018 |
| Toxicities and response rates of secondary CNS lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T cells P Karschnia, K Rejeski, M Winkelmann, F Schöberl, VL Bücklein, ... Neurology 98 (21), 884-889, 2022 | 39 | 2022 |
| Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group P Karschnia, A Dono, JS Young, ST Juenger, N Teske, L Häni, T Sciortino, ... Neuro-oncology 25 (9), 1672-1685, 2023 | 38 | 2023 |
| Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion K Rejeski, A Perez, G Iacoboni, V Blumenberg, VL Bücklein, S Völkl, ... Science Advances 9 (38), eadg3919, 2023 | 37 | 2023 |
| Chimeric antigen receptor T cells for glioblastoma: current concepts, challenges, and future perspectives P Karschnia, N Teske, N Thon, M Subklewe, JC Tonn, J Dietrich, ... Neurology 97 (5), 218-230, 2021 | 37 | 2021 |
| Primary dural lymphomas: clinical presentation, management, and outcome P Karschnia, TT Batchelor, JT Jordan, B Shaw, SF Winter, FJ Barbiero, ... Cancer 126 (12), 2811-2820, 2020 | 37 | 2020 |
| Effects of cryopreservation on adipose tissue‐derived microvascular fragments MW Laschke, P Karschnia, C Scheuer, A Heß, W Metzger, MD Menger Journal of tissue engineering and regenerative medicine 12 (4), 1020-1030, 2018 | 33 | 2018 |
| CAR T-cells for CNS lymphoma: driving into new terrain? P Karschnia, J Blobner, N Teske, F Schöberl, E Fitzinger, M Dreyling, ... Cancers 13 (10), 2503, 2021 | 31 | 2021 |
| Defining treatment‐related adverse effects in patients with glioma: Distinctive features of pseudoprogression and treatment‐induced necrosis SF Winter, EJ Vaios, A Muzikansky, M Martinez‐Lage, MR Bussière, ... The oncologist 25 (8), e1221-e1232, 2020 | 30 | 2020 |
| Artificial intelligence in neurology: opportunities, challenges, and policy implications S Voigtlaender, J Pawelczyk, M Geiger, EJ Vaios, P Karschnia, ... Journal of neurology 271 (5), 2258-2273, 2024 | 28 | 2024 |
| The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy P Karschnia, E Le Rhun, MA Vogelbaum, M van den Bent, SJ Grau, ... European journal of cancer 156, 93-108, 2021 | 27 | 2021 |
